MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials